Holen Sie sich die Stockscreener-App
74.85
1.32%
0.73
Sol Gel Technologies Ltd Aktie (SLGL) Neueste Nachrichten
SLGL Technical Analysis & Stock Price Forecast - Intellectia AI
Opaleye boosts Sol-Gel (SLGL) stake with 1,712-share open-market buy - Stock Titan
Sol-Gel Technologies Ltd. Actuals & Estimates (NASDAQ:SLGL) - TradingView
SLGL Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBIT forward of Sol-Gel Technologies Ltd. – NASDAQ:SLGL - TradingView
Price to sales forward of Sol-Gel Technologies Ltd. – NASDAQ:SLGL - TradingView
Enterprise value to revenue forward of Sol-Gel Technologies Ltd. – NASDAQ:SLGL - TradingView
SLGL Initiates Coverage On Mizuho -- Rating Set to Outperform - GuruFocus
Mizuho Securities Initiates Coverage on Sol-Gel With Outperform Rating, $285 Price Target - Moomoo
This Take-Two Interactive Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Mizuho initiates Sol Gel stock with Outperform on BCC therapy potential - Investing.com South Africa
Sol-Gel Technologies Initiated at Outperform by Mizuho - Moomoo
ETFs Investing in Sol-Gel Technologies Ltd. Stocks - TradingView
Certain Ordinary Shares of Sol-Gel Technologies Ltd. are subject to a Lock-Up Agreement Ending on 22-JUN-2026. - marketscreener.com
Sol Gel Technologies Ltd (SLGL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Sol Gel Technologies Ltd (SLGL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Sol Gel Technologies Ltd (SLGL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Sol Gel Technologies Ltd (SLGL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sol Gel Technologies Ltd (SLGL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Sol Gel Technologies Ltd (SLGL) Institutional Confidence - TradingKey
Sol Gel Technologies Ltd (SLGL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sol Gel Technologies Ltd (SLGL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sol Gel Technologies Ltd (SLGL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SLGL Q1 2026 Earnings: EPS Surprises to the Upside as Cost Discipline Takes HoldDownward Estimate Revision - newsline.com
Phoenix Financial Ltd. (SLGL) reports 4.99% ownership of Sol‑Gel shares - Stock Titan
Sol-Gel Technologies Ltd. Q1 2026 Earnings: EPS Beat Drives Modest Stock Uptick Despite Continued Pre-Revenue StatusGuidance Update - newsline.com
SLGL Q1 2026 Earnings: Smaller-Than-Expected Loss Drives Stock HigherNext Quarter Guidance - newsline.com
SLGLSol-Gel Technologies Ltd Stock Price and Quote - Finviz
TD Cowen initiates Sol Gel stock with buy on dermatology drug - Investing.com Nigeria
LifeSci Capital Maintains Sol-Gel Technologies(SLGL.US) With Buy Rating, Maintains Target Price $184 - Moomoo
TD Cowen Initiates Sol-Gel Technologies at Buy - Moomoo
Sol Gel Technologies Q1 Loss On US$0.1 Million Revenue Fuels Bearish Narrative - simplywall.st
Sol-Gel Technologies (SLGL) Reports First Quarter Revenue Decline - GuruFocus
Sol Gel Tech earnings beat by $3.15, revenue fell short of estimates - Investing.com Australia
Sol-Gel Technologies Ltd. (SLGL) reports Q1 loss, lags revenue estimates - MSN
Sol-Gel Technologies 1Q EPS $1.31 >SLGL - Moomoo
Sol-Gel Technologies Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Sol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Sol-Gel Technologies Expects Cash Resources to Fund Cash Requirements Into 1Q of 2028 >SLGL - Moomoo
BRIEF-Sol-Gel Technologies Ltd. Q1 Revenue USD 100 Thousand - TradingView
Sol-Gel Technologies (NASDAQ: SLGL) trims Q1 2026 loss and strengthens cash runway - Stock Titan
Sol-Gel wins 2044 patent for Gorlin syndrome gel, raises $33M - Stock Titan
Sol-Gel Q1 2026 earnings: loss narrows as R&D declines - grafa.com
Should I buy SolGel Technologies (SLGL) - Zacks Investment Research
Sol-Gel Technologies (SLGL) Holds Steady Just Below Key Resistance After Modest GainSeasonality Effect - The Legal Advocate
SLGL Q4 2025 Earnings: EPS Misses Estimates as Development-Stage Biotech Reports No RevenueProfit Guidance Range - newsline.com
Sol-Gel Technologies (SLGL) Q4 2025 Earnings: Development-Stage Miss Deepens as Losses Widen; Stock SurgesOperating Income Trends - The Legal Advocate
Opaleye-managed fund buys 1,563 Sol-Gel (SLGL) shares in open market - Stock Titan
SLGL SEC FilingsSol Gel Tech 10-K, 10-Q, 8-K Forms - Stock Titan
1.26%
3.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):